Read by QxMD icon Read

International Journal of Technology Assessment in Health Care | Page 2

Pattara Leelahavarong, Suradech Doungthipsirikul, Suthasinee Kumluang, Akanittha Poonchai, Nitichen Kittiratchakool, Danai Chinnacom, Netnapis Suchonwanich, Sripen Tantivess
OBJECTIVES: To explore health technology assessment (HTA) in Thailand focusing on its institutionalization, key elements for HTA introduction, and HTA contribution to policy. METHODS: A review of literature covered a wide range of topics, including the institutionalization of HTA, elements of HTA introduction, and the role of HTA in policy decision making in Thai context. Additional information from the authors' involvement in the policy decision-making process in Thailand was also considered...
June 13, 2019: International Journal of Technology Assessment in Health Care
Don Husereau, Edward Nason, Tarun Ahuja, Enkeleida Nikaï, Eva Tsakonas, Philip Jacobs
BACKGROUND: Canada has a long history of the use of clinical evidence to support healthcare decision making. Given improvements in data holdings and analytic capacity in Canada and stakeholder interest, the purpose of this study is to reflect on perceptions of the value of real-world evidence in pricing and reimbursement decisions, barriers to its optimal use in pricing and reimbursement, current initiatives that may lead to its increased use, and what role the pharmaceutical industry may play in this...
May 28, 2019: International Journal of Technology Assessment in Health Care
Yan Xu, Yan Wei, Jian Ming, Na Li, Ningze Xu, Raymond W Pong, Yingyao Chen
OBJECTIVES: There is little evidence in China regarding the cost-effectiveness of non-invasive prenatal testing (NIPT) for Down syndrome (DS). This study aims to evaluate the cost-effectiveness of NIPT and provide evidence to inform decision-making. METHODS: To determine the cost-effectiveness of NIPT for DS, a decision-analytic model was developed using the TreeAge Pro software from a societal perspective in a simulated cohort of 10 000 pregnant women. Main indicators were based on field surveys from sampled hospitals in four locations in China and a literature review...
May 27, 2019: International Journal of Technology Assessment in Health Care
Maggie MacNeil, Melissa Koch, Don Juzwishin, Paul Stolee
No abstract text is available yet for this article.
May 24, 2019: International Journal of Technology Assessment in Health Care
Linda Mundy, Rebecca Trowman, Brendon Kearney
OBJECTIVES: Discussions at the Health Technology Assessment International (HTAi) Asia Policy Forum (HAPF) aimed to understand the meaning of "high-cost technologies," and to explore mechanisms to increase access to these technologies in publicly funded health systems in the Asia region. METHODS: Discussions and presentations at the 2018 HAPF, informed by a literature review and a premeeting survey of HTA agencies and industry, form the basis of this paper...
May 24, 2019: International Journal of Technology Assessment in Health Care
Saudamini Vishwanath Dabak, Yot Teerawattananon, Thiri Win
OBJECTIVES: Health technology assessment (HTA) has been widely used to inform coverage decisions in high-income countries over the past few decades and has been getting increasing attention in middle-income countries as a tool for healthcare decision making in recent years. This study aims to use the case of the Maternal and Child Health Voucher Scheme (MCHVS) in Myanmar to understand how HTA can have a policy impact in a low or lower middle-income country. METHODS: The stages heuristic framework was used to describe the policy-making process...
May 17, 2019: International Journal of Technology Assessment in Health Care
Arjun Bhadhuri, Hareth Al-Janabi, Sue Jowett, Kate Jolly
OBJECTIVES: It is important to capture all health effects of interventions in cost-utility analyses conducted under a societal or healthcare perspective. However, this is rarely done. Household spillovers (health effects on patients' other household members) may be particularly likely in the context of technologies and interventions to change behaviors that are interdependent in the household. Our objective was to prospectively collect outcome data from household members and illustrate how these can be included in a cost-utility analysis of a behavior change intervention in chronic obstructive pulmonary disease (COPD)...
May 8, 2019: International Journal of Technology Assessment in Health Care
Axel C Mühlbacher, Christin Juhnke
OBJECTIVES: Neuroendocrine tumors (NETs) are rare, slow-growing malignant tumors. So far, there are no data on patient preferences regarding its therapy. This empirical study aimed to elicit patient preferences in the drug treatment of NET. METHODS: Based on qualitative patient interviews and an analytic hierarchy process, six patient-relevant attributes were analyzed and weighted using a discrete-choice experiment. Patients were recruited with the help of a NET support group...
May 2, 2019: International Journal of Technology Assessment in Health Care
Ana Paula Beck da Silva Etges, Veronique Grenon, Elaine Aparecida Felix, Joana Siqueira de Souza, Francisco José Kliemann Neto, Carisi Anne Polanczyk
BACKGROUND: Healthcare organizations have invested efforts on hospital-based health technology assessment (HB-HTA) and enterprise risk management (ERM) processes for novel systems to obtain more accurate data on which to base strategic decisions. This study proposes to analyze how HB-HTA and ERM processes can share personal resources and skills to achieve principles with value-oriented results. METHODS: Literature on ERM and HB-HTA and data from interviews with healthcare managers compose the research data sources, which were submitted to a qualitative data analysis...
April 26, 2019: International Journal of Technology Assessment in Health Care
Nisha D Almeida, Lorraine Mines, Ioana Nicolau, Alison Sinclair, David Felipe Forero, James M Brophy, Nancy Mayo, Nandini Dendukuri
OBJECTIVES: Very few practical frameworks exist to guide the formulation of recommendations at hospital-based health technology assessment (HTA) units. The objectives of our study were: (i) to identify decision criteria specific to the context of hospital-based health technologies and interventions, (ii) to estimate the extent to which the expert community agrees on the importance of the identified criteria, (iii) to incorporate the identified criteria into a decision-aid tool, and (iv) to illustrate the application of a prototype decision-aid tool...
April 24, 2019: International Journal of Technology Assessment in Health Care
Pedro Serrano-Aguilar, José Asua-Batarrita, María Teresa Molina-López, Mireia Espallargues, Joan Pons-Rafols, Sandra García-Armesto, Paloma Arriola-Bolado, Marisa López-García, María José Faraldo-Vallés, Luis María Sánchez-Gómez, Celia Juárez-Rojo, Isabel Prieto-Yerro, Paloma Casado-Durández, Antonio Sarria-Santamera
Earlier activities on health technology assessment (HTA) started in Spain around 1984, with the creation of a National Advisory Board on HTA, and the development of national and regional HTA organizations in the early 1990s. In 2012, the Spanish Health Ministry established the Spanish Network for Health Technology Assessment of the National Health System (RedETS); funded at national level and including all public HTA organizations at national and regional levels. RedETSis focused on the assessment of nondrug health technologies to inform the revision (approval and funding or disinvestment) of the Benefit Portfolio of the Spanish NHS...
April 22, 2019: International Journal of Technology Assessment in Health Care
Julie Polisena, Gerhard Trunk, Iñaki Gutierrez-Ibarluzea, Roberta Joppi
OBJECTIVES: As healthcare decision makers continue to face challenges in health services delivery to their patients, disinvestment programs are being established for a sustainable healthcare system. This study aimed to collect data and information by means of a survey of disinvestment candidates and ongoing disinvestment projects in the health technology assessment (HTA) community. METHODS: An online survey was conducted to collect information on disinvestment candidates and activities from members of the Health Technology Assessment International Disinvestment & Early Awareness Interest Group, the EuroScan International Network and International Network of Agencies for Health Technology Assessment...
April 22, 2019: International Journal of Technology Assessment in Health Care
Wija Oortwijn, Philip Klein
Health technology assessment (HTA) is increasingly used around the globe to inform resource allocation decisions. Furthermore, the importance of using explicit and transparent criteria for coverage decision making in line with health system values has been acknowledged. However, the values of a health system are often not explicitly taken into account in the HTA process. This situation influences the allocation of scarce resources and could lead to a discord between the HTA outcome and the values of the health system...
April 8, 2019: International Journal of Technology Assessment in Health Care
Sabine Vogler, Peter Schneider
OBJECTIVES: There is no established methodology to assess the feasibility of medicine price data sources. Against this backdrop, a framework to guide the selection of most appropriate price data sources for pharmacoeconomic research has been developed. METHODS: A targeted literature review was carried out. Dimensions discussed in literature as relevant for medicine price comparisons and practical experience of the authors in medicine price studies informed the conceptional work of the framework development...
March 29, 2019: International Journal of Technology Assessment in Health Care
Anne Kathrin Stich, Kati Mozygemba, Kristin Bakke Lysdahl, Lisa Maria Pfadenhauer, Bjørn Hofmann, Gert-Jan van der Wilt, Ansgar Gerhardus
OBJECTIVES: Social and cultural aspects are rarely assessed in health technology assessments (HTA), despite being part of most HTA definitions. One hypothesis for the reason why they are hardly considered in HTA is that we lack relevant assessment methods. Accordingly, this review aims at providing an overview of methodological approaches to address social and cultural aspects related to health technologies in HTA. METHODS: We conducted a comprehensive literature search by searching fourteen databases and a hand-search of two pertinent journals...
March 28, 2019: International Journal of Technology Assessment in Health Care
Hisayuki Ogura, Shigekazu Komoto, Takeru Shiroiwa, Takashi Fukuda
OBJECTIVES: Advances in health care due to the development and introduction of new drugs and medical devices have brought considerable benefits to people and patients in terms of upgraded quality of life and extended years of survival. However, some are concerned that the very advancement of health care would increase further the inflation of national healthcare costs. In response to these concerns, Japan's Central Social Insurance Medical Council ("Chuikyo") began in 2012 to examine how cost-effectiveness evaluation might be applied to the national health insurance system, and has been working toward establishing a system for its usage...
March 21, 2019: International Journal of Technology Assessment in Health Care
David M Meads, John L O'Dwyer, Claire T Hulme, Rocio Rodriguez Lopez, Michael I Bennett
OBJECTIVES: Uncontrolled pain in advanced cancer is a common problem and has significant impact on individuals' quality of life and use of healthcare resources. Interventions to help manage pain at the end of life are available, but there is limited economic evidence to support their wider implementation. We conducted a case study economic evaluation of two pain self-management interventions (PainCheck and Tackling Cancer Pain Toolkit [TCPT]) compared with usual care. METHODS: We generated a decision-analytic model to facilitate the evaluation...
March 15, 2019: International Journal of Technology Assessment in Health Care
Ana Toledo-Chávarri, Yolanda Alvarez-Perez, Yolanda Triñanes, Lilisbeth Perestelo-Pérez, Mireia Espallargues, Matilde Palma, Pedro Serrano-Aguilar
OBJECTIVES: The aim of this study was to develop a feasible and effective strategy to involve patients in the Spanish Network of Agencies of Health Technology Assessment (RedETS). METHODS: The framework for patient involvement (PI) in the assessment activities and processes of RedETS were developed through a research project that included: (i) a systematic search of the international literature describing a strategy and/or a methodology linking health technology assessment (HTA) and PI; (ii) a qualitative study through interviews with RedETS members to analyze the perceptions of PI among HTA managers in the Spanish context; (iii) a Delphi consultation with three large platforms of patients, carers and consumer organizations in Spain about their perspectives of PI; (iv) a consensus process with the members of the RedETS Governing Council to define the final strategy...
March 14, 2019: International Journal of Technology Assessment in Health Care
Sarimin Roza, Sabirin Junainah, Mudla Mohamed Ghazali Izzuna, Ku Abdul Rahim Ku Nurhasni, Mohd Aminuddin Mohd Yusof, Md Darus Noormah, Md Fuzi Syful Azlie, Lee Sit Wai
OBJECTIVES: The aim of this study was to provide a comprehensive overview of the evolution of health technology assessment (HTA) in Malaysia over the past decade. METHODS: We described the evolution of HTA program in Malaysia based on review of administrative data, publicly available information and quantitative description of impact evaluation. RESULTS: Health Technology Assessment HTA was formalized in Malaysia in 1995 as a central structure within the Ministry of Health, Malaysia in 1995...
March 13, 2019: International Journal of Technology Assessment in Health Care
Sil-Ling Pruis, Mohamed Ismail Abdul Aziz, Fiona Pearce, Min Han Tan, David Bin-Chia Wu, Kwong Ng
OBJECTIVES: This study was conducted to evaluate the cost-effectiveness of sunitinib versus interferon-alfa for the treatment of advanced and/or metastatic renal cell carcinoma (RCC) in Singapore. METHODS: A partitioned survival model with three health states (progression-free, progressive disease, and death) was developed from a healthcare payer perspective over a 10-year time horizon. Survival curves from the pivotal trial of sunitinib versus interferon-alfa were extrapolated beyond the trial period to estimate the underlying progression-free survival and overall survival parametric distributions...
March 11, 2019: International Journal of Technology Assessment in Health Care
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"